About DARZALEX® DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj),Business Directories,Company Directories

companydirectorylist.com Global Business Directories and Company Directories

Country Lists

USA Company Directories

Canada Business Lists

Australia Business Directories

France Company Lists

Italy Company Lists

Spain Company Directories

Switzerland Business Lists

Austria Company Directories

Belgium Business Directories

Hong Kong Company Lists

China Business Lists

Taiwan Company Lists

United Arab Emirates Company Directories

Industry Catalogs

USA Industry Directories

English Français Deutsch Español 日本語 한국의 繁體简体 Português Italiano Русский हिन्दी ไทย Indonesia Filipino Nederlands Dansk Svenska Norsk Ελληνικά Polska Türkçe العربية

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
Learn about adult treatment with DARZALEX® and DARZALEX FASPRO® See Full Prescribing Safety Information
How is Treatment Given - DARZALEX FASPRO® (daratumumab and . . .
Learn how treatment is given across both DARZALEX® and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) See Full Prescribing Safety Information
What is multiple myeloma? - DARZALEX FASPRO® (daratumumab and . . .
DARZALEX is a prescription medicine used alone to treat adults with high-risk smoldering multiple myeloma (an early form of multiple myeloma that has a higher chance of progressing to active multiple myeloma) It is not known if DARZALEX FASPRO ® is safe and effective in children
Preparing For Treatment | DARZALEX® DARZALEX FASPRO® (daratumumab and . . .
Find out what you can expect before, during, and after treatment with DARZALEX® and DARZALEX FASPRO® See Full Prescribing Safety Information
About DARZALEX® DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
DARZALEX FASPRO ® and DARZALEX ® are prescription medicines used alone or in combination with one or more treatments for adults with a rare form of blood cancer called multiple myeloma
Side Effects | DARZALEX® DARZALEX FASPRO® (daratumumab and . . .
DARZALEX FASPRO ® and DARZALEX ® can decrease white blood cell counts, which help fight infections, and blood cells called platelets, which help to clot blood
Clinical Results | DARZALEX® DARZALEX FASPRO® (daratumumab and . . .
See DARZALEX® DARZALEX FASPRO® clinical results, including additional studies for newly diagnosed relapsed or refractory patients See Full Prescribing Safety Info
SELECT IMPORTANT SAFETY INFORMATION - DARZALEX FASPRO® (daratumumab . . .
In a clinical study, patients on DARZALEX FASPRO® experienced results comparable to the intravenous (IV) formulation of DARZALEX® (daratumumab) in treating multiple myeloma when used as monotherapy (by itself)